Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma

Clinical trial NCT00263640 · COMPLETED

Trial details

NCT number: NCT00263640
Sponsor: Allergopharma GmbH & Co. KG
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Respiratory Hypersensitivity

Start date: 2005-05-01
Primary completion: 2009-04-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.